CathRx is an Australian-based medical device company principally involved in the development and manufacture of innovative, low cost, high quality electrophysiology catheters for the diagnosis and treatment of cardiac arrhythmias. The company’s proprietary technology platform circumvents the technological limitations associated with conventional single-use catheter design.  The technology which is incorporated into the company’s new Khelix™ range of catheters, will help hospitals reduce their economic and environmental costs by allowing reprocessing of the catheters by their on-site central sterilisation departments. The company has regulatory approval for its first release of diagnostic catheters and is actively pursuing strategic alliances with distribution partners.


Multi use devices are not avaliable for sale in the United States


25th January 2016

CathRx receives European regulatory approval (CE) for initial range of diagnostic catheters.

20th December 2016

Pro rata non-renounceable entitlement offer

Download PDF